In eight days, an artificial intelligence company most people had never heard of became a household name. It happened because a CEO sat across from the United States Secretary of War in the Pentagon, heard an ultimatum, and said no. This is the most complete account assembled so far of what happened, what it means, and where it goes from here.

17.9 million people worldwide are living with rheumatoid arthritis. The clinical assumption underlying there treatment plans is about to break. CAR-T cell therapy could offer drug-free remission.

The conventional narrative says frontier technology requires massive capital. These women are proving the opposite: capital efficiency isn’t about doing less with less—it’s about achieving breakthrough outcomes through architecture that compounds rather than burns resources.

Intel Loihi 3 and IBM NorthPole achieve 1,000x GPU efficiency. The neuromorphic revolution just ended NVIDIA’s edge AI monopoly—and the strategic implications cascade across robotics, autonomous vehicles, and distributed intelligence deployment.